1192 Distinguishing Melanophages From Melanoma in Metastatic Melanoma Treated With T-Vec: A Clinical Application of Quantitative Multiplex Immunofluorescence

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.03.1207
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2019English

Multiplex Quantitative Analysis of Cancer-Associated Fibroblasts and Immunotherapy Outcome in Metastatic Melanoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab

Journal of Cutaneous Immunology and Allergy
2019English

Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

iTRAQ Quantitative Proteomic Comparison of Metastatic and Non-Metastatic Uveal Melanoma Tumors

PLoS ONE
Multidisciplinary
2015English

Down-Regulation of the Interferon Signaling Pathway in T Lymphocytes From Patients With Metastatic Melanoma

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2007English

Targeting Metastatic Melanoma

American Journal of Health-System Pharmacy
MedicineHealth PolicyPharmacologyPharmacy
2008English

Rechallenge With Checkpoint Inhibitors in Metastatic Melanoma

JDDG - Journal of the German Society of Dermatology
Dermatology
2020English

Prognostic Factors Related to Clinical Response in Patients With Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade

Clinical Cancer Research
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy